Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-024448
Filing Date
2018-04-09
Accepted
2018-04-09 20:13:19
Documents
2
Period of Report
2018-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1636
2 POA DOCUMENT poa.txt EX-24.3_783358 2171
  Complete submission text file 0001209191-18-024448.txt   5229
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUNRUN INC. 595 MARKET STREET, 29TH FLOOR SAN FRANCISCO CA 94105
Business Address
Kim Mina (Reporting) CIK: 0001668163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36548 | Film No.: 18746662